GlycoCheck is particularly useful in detecting microvascular dysfunction, which is a key contributor to several chronic conditions, including:

• Diabetes & Pre-Diabetes – GlycoCheck helps identify damage before major complications arise.

• Cardiovascular Disease & Hypertension – Provides insights into vascular health beyond traditional cholesterol and blood pressure.

• Chronic Inflammation & Autoimmune Diseases – Helps detect systemic inflammation and quantify its damage.

• Neurodegenerative Diseases – Poor microcirculation is linked to Alzheimer’s and cognitive decline.

• Long COVID & Post-Viral Syndromes – Assesses lingering vascular damage from viral infections.

• Kidney Disease – Detects microvascular impairment that contributes to chronic kidney disease (CKD) and diabetic nephropathy.

• Erectile Dysfunction (ED) – Since ED is often a microvascular issue, GlycoCheck can identify endothelial dysfunction before symptoms become severe.

  Because many diseases start at the microvascular level, GlycoCheck provides early-warning insights, helping doctors tailor prevention and treatment plans.

GlycoCheck is backed by over 200 peer-reviewed research and clinical studies demonstrating its ability to detect microvascular dysfunction across various conditions.

It has been used in top medical research institutions worldwide, including Duke University Medical Center, Mayo Clinic, University of Cambridge, University of Oxford, School for Cardiovascular Diseases, and more.

GlycoCheck provides quantifiable, reproducible, and predictive data on vascular health, making it a highly reliable tool for both clinical, research, and diagnostic applications.

GlycoCheck is designed for easy implementation in functional medicine, cardiology, endocrinology, and integrative health practices.

The system utilizes a hand-held video microscope, making it non-invasive and quick to use.

A single test takes only a few minutes and requires minimal patient prep.

The software automatically analyzes results, providing a clear Microvascular Health Score with actionable insights.

Training is minimal, and full customer support is available to ensure smooth integration. Adding GlycoCheck to your practice enhances diagnostic capabilities while providing cutting-edge patient care.

For Patients:

Provides early detection of hidden vascular issues

Helps personalize treatment plans for chronic disease prevention and management

Supports proactive health monitoring, especially for high-risk individuals

Targeted treatment creates better outcomes

For Your Practice:

Positions your clinic as a leader in advanced vascular diagnostics

Helps differentiate your practice with unique, research-backed technology

Can increase patient engagement and retention through ongoing microvascular health tracking

Increases revenue through additional diagnostic and treatment programs

GlycoCheck requires a one-time equipment investment plus an annual software license fee to ensure all new studies and improvements are available to you and your patients.

The test can be billed as part of cardiovascular or metabolic risk assessments in many cases.

Depending on your patient base, cash-based pricing models (e.g., wellness memberships, integrative consultations) can provide additional revenue within days and profit cash flow within 4-8 weeks.

Because GlycoCheck delivers high-value preventive insights, it aligns well with functional and concierge medicine models where patients seek deeper health assessments beyond standard labs.